Stock Comparison

GILD vs LLY

Gilead Sciences Inc and Eli Lilly and Company side by side — valuation, profitability, growth and risk.

GILD

Gilead Sciences Inc

Healthcare

LLY

Eli Lilly and Company

Healthcare

Valuation

Market Cap

$171.48B

$1.04T

P/E (TTM)

—

39.1

Forward P/E

15.8

32.1

Price/Sales

5.6

13.0

Price/Book

14.5

30.6

EV/EBITDA

104.8

26.0

Dividend Yield

1.74%

0.53%

Profitability

Net Margin

30.99%

33.53%

Operating Margin

38.61%

43.92%

Return on Equity

-20.70%

102.30%

Return on Assets

14.10%

20.40%

Growth (YoY)

Revenue Growth

10.20%

47.70%

Earnings Growth

54.80%

26.20%

Price & Risk

Beta

0.3

0.5

52-Week High

$154.92

$1,235.65

52-Week Low

$109.22

$679.67

Analyst Target

$157.41

$1,297.31

Compare GILD and LLY your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.